|
Delivery vehicle/s | Route of transfer | Method | TM | Advantages | Disadvantages | Applications | References |
|
Colloidal nanoparticles | Intranasal | Direct | DF* | Noninvasive and safe, neuroprotective | Poor release of drug | Use for delivery of local ailments of cold cough | [34] |
|
Lipid nanoparticles | Intraventricular | Direct | DF | Enhance drug efficacy, neuroprotective | Toxic to membranes | Rhinitis and ischemic brain injury, for tumor, and global ischemia | [34] |
|
Direct injection | Intraventricular | Direct | DF | Less toxic, impose fewer side effects, and neuroprotective | Invasive and toxic | Use for delivery of pain medication within the CSF | [49] |
|
Prodrugs | Oral or intranasal | Direct/indirect | DF | Tissue targeted delivery of lipophilic molecules, safe | Poor biological activity | Largely used to treat neuronal diseases | [25] |
|
Peptide masking | Injection | Direct | DF/RMT** | Cholesteryl group traverse the drug through BBB | Poor biological activity | Multiple sclerosis, cancer and tumor | [28] |
|
Proteins | Transcapillary | Indirect | RMT | Less toxic, effective and safe, and neuroprotective | Difficult transport | Effective against cerebral ischemia, neurorepair after trauma | [58] |
|
Chimeric peptides | Transcapillary$ | Indirect | RMT | Targeted drug delivery, stable during transcytosis | Less permeable | Effective in treatment of various neurodegenerative diseases | [59] |
|
Radionuclides# | Transcapillary | Indirect | DF/contact | Tumor detection and ablation, low dose, and neuroprotective | Necrosis and lesions | Neuroimaging of brain and neuroendocrine tumors | [60] |
|
LMEFU*** | Intraventricular | Indirect | DF | Noninvasive, distribute drug reversibly, and neuroprotective | Cause structural injury | Cancer and tumor therapeutics, neurodegenerative diseases | [61] |
|
Proline rich peptides | Transcapillary | Indirect | DF/RMT | Less toxic, safe and effective, and neuroprotective | Catalytically unstable | Use for treatment of cerebral infections neurocognitive disorders | [62] |
|